(Q40512232)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15386354%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

title

MAZ51, an indolinone that inhibits endothelial cell and tumor cell growth in vitro, suppresses tumor growth in vivo (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15386354%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

0 references

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15386354%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Johannes Waltenberger

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15386354%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Jonathan P. Sleeman

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15386354%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

author name string

Wilko Thiele

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15386354%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Petra Baumann

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15386354%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Ralph Mazitschek

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15386354%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Katrin Rohde

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15386354%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Guido Fellbrich

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15386354%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Herbert Weich

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15386354%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Athanassios Giannis

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15386354%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

language of work or name

English

0 references

publication date

1 December 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15386354%20AND%20SRC:MED&resulttype=core&format=json

International Journal of Cancer

2 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15386354%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

volume

112

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15386354%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15386354%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

page(s)

986-993

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15386354%20AND%20SRC:MED&resulttype=core&format=json

Vascular growth factors and lymphangiogenesis

2 January 2020

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1002%2FIJC.20509

Suppression of tumor lymphangiogenesis and lymph node metastasis by blocking vascular endothelial growth factor receptor 3 signaling.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1002%2FIJC.20509